For citations:
Mochkin N.E., Shorokhov N.S., Sarzhevskiy V.O., Bogatyrev V.S., Samoylova A.A., Rukavitsyn A.A., Smirnova E.G., Bannikova A.E., Mamedova A.A., Protopopova Yu.V., Melnichenko V.Ya. Netupitant / palonosetron with dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous hematopoietic stem cell transplantation: a single-center experience. Oncohematology. 2025;20(1):146-153. (In Russ.) https://doi.org/10.17650/1818-8346-2025-20-1-146-153
Email this article 